All sponsors

Sinovac Life Sciences Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS3
Open Sinovac Life Sciences Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Sinovac PCV13
NCT06617715
P3RecruitingPneumococcal Infectious Disease30802026-05-12 (+14 mo)
Oral hexavalent reassortant rotavirus attenuated live vaccine
NCT06967272
P2RecruitingRotavirus Gastroenteritis4002026-06-15
Sinovac PCV24
NCT07300644
P2RecruitingPneumococcal Infectious Disease4202026-09
Sinovac PCV13 lot 1
NCT07832500
P3Not yet recruitingPneumococcal Infectious Diseases11252027-03
SNA02-48
NCT07633119
P3Not yet recruitingTetanus6002027-03-31
Sinovac PCV13
NCT07593924
P3Not yet recruitingPneumococcal Infectious Diseases5002027-07